In summary, the present study showed that LPS-induced anxiety and depression-like behaviors might be associated with brain RAS activation, neuroinflammation and disturbed brain insulin signaling, which were partly restored by Cand treatment, highlighting the involvement of RAS in inflammation-impeded insulin pathway in the brain and providing a potential drug target for the inflammation-associated neurological disorders such as depression. The gene discussed is INS; the disease is Anxiety.